GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai HeartCare Medical Technology Corp Ltd (HKSE:06609) » Definitions » 5-Year Yield-on-Cost %

Shanghai HeartCare Medical Technology (HKSE:06609) 5-Year Yield-on-Cost % : 0.00 (As of Jun. 07, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai HeartCare Medical Technology 5-Year Yield-on-Cost %?

Shanghai HeartCare Medical Technology's yield on cost for the quarter that ended in Dec. 2023 was 0.00.


The historical rank and industry rank for Shanghai HeartCare Medical Technology's 5-Year Yield-on-Cost % or its related term are showing as below:



HKSE:06609's 5-Year Yield-on-Cost % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.12
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Shanghai HeartCare Medical Technology's 5-Year Yield-on-Cost %

For the Medical Devices subindustry, Shanghai HeartCare Medical Technology's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai HeartCare Medical Technology's 5-Year Yield-on-Cost % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai HeartCare Medical Technology's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Shanghai HeartCare Medical Technology's 5-Year Yield-on-Cost % falls into.



Shanghai HeartCare Medical Technology 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Shanghai HeartCare Medical Technology is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Shanghai HeartCare Medical Technology  (HKSE:06609) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Shanghai HeartCare Medical Technology 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Shanghai HeartCare Medical Technology's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai HeartCare Medical Technology (HKSE:06609) Business Description

Traded in Other Exchanges
N/A
Address
No. 356, Zhengbo Road, Floor 1 and 3, Building 38, Pilot Free Trade Zone, Lingang New District, Shanghai, CHN
Shanghai HeartCare Medical Technology Corp Ltd is an innovative neuro-interventional medical device company. The company is committed to creating high-quality products for the prevention and treatment of stroke. Geographically, the Group's revenue is derived from Mainland China.
Executives
Ding Kui 2201 Interest of corporation controlled by you
Wisary Limited 2101 Beneficial owner
Wang Guohui
Shanghai Zandaqian Enterprise Management Consulting Center
Lyfe Capital Management Limited
Lyfe Capital Fund Iii (dragon), L.p.
Shanghai Weiyun Enterprise Management Consulting Partnership (lp)
Lyfe Columbia River Limited
Temasek Holdings (private) Limited
Elbrus Investments Pte. Ltd.
Fullerton Management Pte Ltd
Temasek Life Sciences Private Limited

Shanghai HeartCare Medical Technology (HKSE:06609) Headlines

No Headlines